The density and type of MECA‐79‐positive high endothelial venules correlate with lymphocytic infiltration and tumour regression in primary cutaneous melanoma
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Aims: Tumour‐infiltrating lymphocytes have prognostic value in malignant melanoma. High endothelial venules (HEV s) are specialized vessels present in lymph nodes and tertiary lymphoid organs. CCL 19, CCL 21 and CCR 7 regulate lymphocyte migration through HEV s. The aim of our study was to correlate HEV density in cutaneous primary and metastatic malignant melanomas with clinicopathological parameters, and with CCL 19, CCL 21 and CCR 7 m RNA expression. Methods and results: High endothelial venule density was evaluated by immunohistochemistry with a specific antibody, MECA‐79, and chemokine expression was evaluated by real‐time PCR. MECA‐79‐positive vessels, covered by cuboidal (C‐HEV) or flat (F‐HEV) endothelium, were detected in 55% of melanomas. HEV density was higher in primary melanomas than in metastases. Positive correlations were found between C‐HEV density and lymphocytic infiltration, and between F‐HEV density and tumour regression. Cases in which the number of C‐HEV s exceeded that of F‐HEV s had higher levels of CCL 19, CCL 21, and CCR 7. Conclusions: Our results support a predominant role for C‐HEV in the recruitment of lymphocytes in cutaneous melanomas, mediated by CCL 19 and CCL 21, whereas the density of F‐HEV strongly correlates with tumour regression, Therefore, cuboidal and flat HEV s may serve as indicators of the active and late quiescent phases, respectively, of tumour regression in cutaneous malignant melanoma.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method
Livak, K. J., & Schmittgen, T. D. (2001) · Methods · doi:10.1006/meth.2001.1262 · Cited by 180,860
HEVs, lymphatics and homeostatic immune cell trafficking in lymph nodes
Girard, J.-P., Moussion, C., & Förster, R. (2012) · Nature Reviews Immunology · doi:10.1038/nri3298 · Cited by 713
Epidemiology of invasive cutaneous melanoma
MacKie, R. M., Hauschild, A., & Eggermont, A. M. M. (2009) · Annals of Oncology · doi:10.1093/annonc/mdp252 · Cited by 405 · cited 1×
“Although, in the early stages, it is usually curable by surgical resection, the rates of mortality in metastatic melanoma are still high, because of an almost complete absence of a truly effective treatment for this malignancy.(1,2) A series of complex interactions and signalling pathways between tumour cells and the…”
Background
Cited by
B cells and tertiary lymphoid structures promote immunotherapy response
Helmink, B. A., Reddy, S. M., Gao, J., Zhang, S., Basar, R., Thakur, R., Yizhak, K., Sade-Feldman, M., Blando, J., Han, G., et al. (2020) · Nature · doi:10.1038/s41586-019-1922-8 · Cited by 2,731
“…understood 14,15,19-24 – with some studies suggesting that they are tumor-promoting while others show a positive association with improved cancer outcomes, particularly when they are found in association with organized lymphoid aggregates known as tertiary lymphoid structures (TLS) 12,13,16,25-27 .”
STING Agonists as Cancer Therapeutics
Amouzegar, A., Chelvanambi, M., Filderman, J., Storkus, W., & Luke, J. (2021) · Cancers · doi:10.3390/cancers13112695 · Cited by 395
Migrating into the tumor: a roadmap for T cells
van der Woude, L. L., Gorris, M. A. J., Halilovic, A., Figdor, C. G., & de Vries, I. J. M. (2017) · Trends in cancer · doi:10.1016/j.trecan.2017.09.006 · Cited by 307
Control of CD8 T-Cell Infiltration into Tumors by Vasculature and Microenvironment
(2015) · Advances in Cancer Research · doi:10.1016/bs.acr.2015.05.001 · Cited by 159
Cytokine and Chemokine Signals of T‐Cell Exclusion in Tumors
Zhang, Y., Guan, X.-Y., & Jiang, P. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.594609 · Cited by 133
Blocking Tumor Necrosis Factor α Enhances CD8 T-cell–Dependent Immunity in Experimental Melanoma
Bertrand, F., Rochotte, J., Colacios, C., Montfort, A., Tilkin-Mariamé, A.-F., Touriol, C., Rochaix, P., Lajoie-Mazenc, I., Andrieu-Abadie, N., Levade, T., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-2524 · Cited by 113
Metadata
- Authors
- Avram, G., Sánchez‐Sendra, B., Martín, J. M., Terrádez, L., Ramos, D., & Monteagudo, C.
- Venue
- Histopathology
- Publisher
- Wiley
- Published
- 2013-09-14
- Volume
- 63
- Issue
- 6
- Pages
- 852-861
- ISSN
- 0309-0167 (ISSN-L)
- 1365-2559
- OpenAlex
- W1992364481
- Cited by
- 49
- References
- 3
- FWCI
- 1.26
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.